These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 29338913)

  • 1. Discrepancies in staging, treatment, and delays to treatment may explain disparities in bladder cancer outcomes: An update from the National Cancer Data Base (2004-2013).
    Weiner AB; Keeter MK; Manjunath A; Meeks JJ
    Urol Oncol; 2018 May; 36(5):237.e9-237.e17. PubMed ID: 29338913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sociodemographic and survival disparities for histologic variants of bladder cancer.
    Jue JS; Koru-Sengul T; Moore KJ; Miao F; Alameddine M; Nahar B; Punnen S; Parekh DJ; Ritch CR; Gonzalgo ML
    Can J Urol; 2018 Feb; 25(1):9179-9185. PubMed ID: 29524972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delays in radical cystectomy for muscle-invasive bladder cancer.
    Chu AT; Holt SK; Wright JL; Ramos JD; Grivas P; Yu EY; Gore JL
    Cancer; 2019 Jun; 125(12):2011-2017. PubMed ID: 30840335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Race modifies survival benefit of guideline-based treatment: Implications for reducing disparities in muscle invasive bladder cancer.
    Washington SL; Gregorich SE; Meng MV; Suskind AM; Porten SP
    Cancer Med; 2020 Nov; 9(22):8310-8317. PubMed ID: 32869516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Racial/ethnic disparities in access to care and survival for patients with early-stage hepatocellular carcinoma.
    Mathur AK; Osborne NH; Lynch RJ; Ghaferi AA; Dimick JB; Sonnenday CJ
    Arch Surg; 2010 Dec; 145(12):1158-63. PubMed ID: 21173289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disparities in Bladder Cancer Treatment and Survival Amongst Elderly Patients with a Pre-existing Mental Illness.
    Sathianathen NJ; Fan Y; Jarosek SL; Konety I; Weight CJ; Vinogradov S; Konety BR
    Eur Urol Focus; 2020 Nov; 6(6):1180-1187. PubMed ID: 30797737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Socioeconomic Factors Affect Presentation Stage and Survival in Sinonasal Squamous Cell Carcinoma.
    Jafari A; Shen SA; Qualliotine JR; Lehmann AE; Humphreys IM; Abuzeid WM; Bergmark RW; Gray ST
    Laryngoscope; 2021 Nov; 131(11):2421-2428. PubMed ID: 33844294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment and survival vary by race/ethnicity in patients with anaplastic thyroid cancer.
    Roche AM; Fedewa SA; Shi LL; Chen AY
    Cancer; 2018 Apr; 124(8):1780-1790. PubMed ID: 29409119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of treatment at minority-serving hospitals on outcomes for bladder cancer.
    Fletcher SA; Gild P; Cole AP; Vetterlein MW; Kibel AS; Choueiri TK; Sonpavde GP; Preston MA; Pucheril D; Menon M; Sun M; Lipsitz SR; Trinh QD
    Urol Oncol; 2018 May; 36(5):238.e7-238.e17. PubMed ID: 29454591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population-based assessment of racial/ethnic differences in utilization of radical cystectomy for patients diagnosed with bladder cancer.
    Williams SB; Huo J; Kosarek CD; Chamie K; Rogers SO; Williams MA; Giordano SH; Kim SP; Kamat AM
    Cancer Causes Control; 2017 Jul; 28(7):755-766. PubMed ID: 28477210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Which treatment is best for patients with AJCC stage IV bladder cancer?
    Mao W; Ma B; Huang X; Gu S; Luo M; Fan J; Geng J
    Int Urol Nephrol; 2019 Jul; 51(7):1145-1156. PubMed ID: 30949839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pretreatment neutrophil-to-lymphocyte ratio is associated with advanced pathologic tumor stage and increased cancer-specific mortality among patients with urothelial carcinoma of the bladder undergoing radical cystectomy.
    Viers BR; Boorjian SA; Frank I; Tarrell RF; Thapa P; Karnes RJ; Thompson RH; Tollefson MK
    Eur Urol; 2014 Dec; 66(6):1157-64. PubMed ID: 24630414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment Patterns and Overall Survival Outcomes of Octogenarians with Muscle Invasive Cancer of the Bladder: An Analysis of the National Cancer Database.
    Fischer-Valuck BW; Rao YJ; Rudra S; Przybysz D; Germino E; Samson P; Baumann BC; Gay H; Michalski J
    J Urol; 2018 Feb; 199(2):416-423. PubMed ID: 28842247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radical Cystectomy
    Haque W; Verma V; Butler EB; Teh BS
    Anticancer Res; 2017 Oct; 37(10):5603-5608. PubMed ID: 28982876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends and Disparities in Next-Generation Sequencing in Metastatic Prostate and Urothelial Cancers.
    Hage Chehade C; Jo Y; Gebrael G; Tripathi N; Sayegh N; Chigarira B; Mathew Thomas V; Galarza Fortuna G; Narang A; Campbell P; Gupta S; Maughan BL; Roy S; Agarwal N; Swami U
    JAMA Netw Open; 2024 Jul; 7(7):e2423186. PubMed ID: 39023888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Demographic and Survivorship Disparities in Non-muscle-invasive Bladder Cancer in the United States.
    Seo M; Langabeer Ii JR
    J Prev Med Public Health; 2018 Sep; 51(5):242-247. PubMed ID: 30286596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment Patterns and Survival Outcomes for Patients with Small Cell Carcinoma of the Bladder.
    Fischer-Valuck BW; Rao YJ; Henke LE; Rudra S; Hui C; Baumann BC; Gay HA; Michalski JM
    Eur Urol Focus; 2018 Dec; 4(6):900-906. PubMed ID: 28919521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of platinum-based adjuvant chemotherapy for muscle-invasive bladder cancer: A weighted propensity score analysis.
    Shimizu F; Muto S; Taguri M; Ieda T; Tsujimura A; Sakamoto Y; Fujita K; Okegawa T; Yamaguchi R; Horie S
    Int J Urol; 2017 May; 24(5):367-372. PubMed ID: 28281310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival disparities in non-small cell lung cancer by race, ethnicity, and socioeconomic status.
    Tannenbaum SL; Koru-Sengul T; Zhao W; Miao F; Byrne MM
    Cancer J; 2014; 20(4):237-45. PubMed ID: 25098282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex disparities in use of chemotherapy and survival in patients with advanced bladder cancer.
    Rose TL; Deal AM; Nielsen ME; Smith AB; Milowsky MI
    Cancer; 2016 Jul; 122(13):2012-20. PubMed ID: 27224661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.